Latest Insider Transactions at Upstream Bio, Inc. (UPB)
This section provides a real-time view of insider transactions for Upstream Bio, Inc. (UPB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Upstream Bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Upstream Bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2024
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
825,000
+12.66%
|
$14,025,000
$17.0 P/Share
|
|
Oct 15
2024
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
3,609,789
+42.58%
|
-
|
|
Oct 15
2024
|
Erez Chimovits Director |
BUY
Open market or private purchase
|
Indirect |
825,000
+12.66%
|
$14,025,000
$17.0 P/Share
|
|
Oct 15
2024
|
Erez Chimovits Director |
BUY
Conversion of derivative security
|
Indirect |
3,609,789
+42.58%
|
-
|
|
Oct 15
2024
|
Ai Upstream LLC |
BUY
Conversion of derivative security
|
Direct |
4,319,410
+29.86%
|
-
|
|
Oct 15
2024
|
Ai Upstream LLC |
BUY
Open market or private purchase
|
Direct |
1,175,000
+50.0%
|
$19,975,000
$17.0 P/Share
|
|
Oct 15
2024
|
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. |
BUY
Conversion of derivative security
|
Direct |
894,733
+50.0%
|
-
|